Cargando…

A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy

Background: Unnecessary biopsies and overdiagnosis of prostate cancer (PCa) remain a serious healthcare problem. We have previously shown that urine- and plasma-based prostate-specific biomarkers when combined can predict high grade prostate cancer (PCa). To further validate this test, we performed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albitar, Maher, Ma, Wanlong, Lund, Lars, Shahbaba, Babak, Uchio, Edward, Feddersen, Soren, Moylan, Donald, Wojno, Kirk, Shore, Neal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595085/ https://www.ncbi.nlm.nih.gov/pubmed/28900493 http://dx.doi.org/10.7150/jca.20031

Ejemplares similares

Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System
por: Albitar, Maher, et al.
Publicado: (2016)

Synonymous Polymorphisms in HOXB13 as a Protective Factor for Prostate Cancer
por: Albitar, Ferras, et al.
Publicado: (2015)

Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens
por: Nagpal, Kunal, et al.
Publicado: (2020)

Correlation of MRI-Lesion Targeted Biopsy vs. Systematic Biopsy Gleason Score with Final Pathological Gleason Score after Radical Prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists
por: Bulten, Wouter, et al.
Publicado: (2020)

Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
por: Oh, Jong Jin, et al.
Publicado: (2021)

The correlation between the gleason score of the biopsy and that of the prostatectomy patch
por: Bai, W., et al.
Publicado: (2021)

Gene function classification using Bayesian models with hierarchy-based priors
por: Shahbaba, Babak, et al.
Publicado: (2006)

The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers
por: Ball, Richard Y., et al.
Publicado: (2021)

pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies
por: Kim, Sung Jin, et al.
Publicado: (2011)

Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies
por: Lucas, Marit, et al.
Publicado: (2019)

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
por: Wang, Hanfeng, et al.
Publicado: (2017)

Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer
por: Nagpal, Kunal, et al.
Publicado: (2019)

Biostatistics with R: An Introduction to Statistics Through Biological Data
por: Shahbaba, Babak
Publicado: (2012)

Erratum: pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies
Publicado: (2011)

Gleason grading of prostate cancer in needle core biopsies: a comparison of general and urologic pathologists
por: Al-Maghrabi, Jaudah Ahmed, et al.
Publicado: (2013)

Correlation between body mass index (BMI) and the Gleason score of prostate biopsies in Chinese population
por: Zhou, Feng, et al.
Publicado: (2016)

Real-time diagnosis and Gleason grading of prostate core needle biopsies using nonlinear microscopy
por: Cahill, Lucas C., et al.
Publicado: (2021)

Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer
por: Mori, Keiichiro, et al.
Publicado: (2021)

Predictive Factors of Gleason Score Upgrading in Localized and Locally Advanced Prostate Cancer Diagnosed by Prostate Biopsy
por: Moon, Seung Jin, et al.
Publicado: (2010)

Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors
por: Albitar, Maher, et al.
Publicado: (2023)

Structural effects of clinically observed mutations in JAK2 exons 13-15: comparison with V617F and exon 12 mutations
por: Lee, Tai-Sung, et al.
Publicado: (2009)

Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits
por: Ma, Wanlong, et al.
Publicado: (2017)

Using high-sensitivity sequencing for the detection of mutations in BTK and PLCγ2 genes in cellular and cell-free DNA and correlation with progression in patients treated with BTK inhibitors
por: Albitar, Adam, et al.
Publicado: (2017)

Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy
por: Fiorentino, Vincenzo, et al.
Publicado: (2020)

Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer
por: Kayano, Paulo Priante, et al.
Publicado: (2018)

An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading
por: Tolkach, Yuri, et al.
Publicado: (2023)

Predictive Factors and Oncologic Outcome of Downgrade to Pathologic Gleason Score 6–7 after Radical Prostatectomy in Patients with Biopsy Gleason Score 8–10
por: Chung, Doo Yong, et al.
Publicado: (2019)

Prostate Cancer in Patients with Metabolic Syndrome Is Associated with Low Grade Gleason Score When Diagnosed on Biopsy
por: Jeon, Kyoung Pil, et al.
Publicado: (2012)

Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study
por: Rapiti, Elisabetta, et al.
Publicado: (2013)

Prostate cancer: Relationship between vascular diameter, shape and density and Gleason score in needle biopsy specimens
por: Tadayyon, Farhad, et al.
Publicado: (2013)

Publisher Correction: Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer
por: Nagpal, Kunal, et al.
Publicado: (2019)

Re: Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer
por: Bozkurt, Ibrahim Halil, et al.
Publicado: (2019)

Can Contemporary Patients with Biopsy Gleason Score 3+4 Be Eligible for Active Surveillance?
por: Kwon, Ohseong, et al.
Publicado: (2014)

Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012)

Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study
por: Pereira, Renan A, et al.
Publicado: (2015)

Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi‐institutional analysis
por: Barsky, Andrew R., et al.
Publicado: (2020)

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance
por: Tomer, Anirudh, et al.
Publicado: (2020)

The prevalence and risk factors of upgrading of Gleason grade group between transrectal ultrasound prostate biopsy and prostatectomy specimens
por: Promsen, Worapong, et al.
Publicado: (2023)

Lectures on Gleason parts
por: Bear, Herbert S
Publicado: (1970)

Cannot write session to /tmp/vufind_sessions/sess_sifptk53h4drh1nbvf31dossu1